Benson Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.29K Hold
8
– – ﹤0.01% 324
2026
Q2
$1.52K Hold
8
– – ﹤0.01% 310
2026
Q1
$1.58K Hold
8
– – ﹤0.01% 291
2025
Q4
$1.47K Buy
+8
New +$1.4K ﹤0.01% 288

Other funds holding AZN

Benson Wealth Management's AZN Position: Q3 2026 in Review

Benson Wealth Management held its AstraZeneca (AZN) position steady in Q3 2026 at 8 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #324.

Benson Wealth Management first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.58K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Benson Wealth Management held 8 shares of AstraZeneca worth $1.29K as of Q3 2026.
  • Benson Wealth Management left its AstraZeneca share count unchanged in Q3 2026.
  • AstraZeneca made up ﹤0.01% of Benson Wealth Management's portfolio in Q3 2026, its #324 holding.
  • Benson Wealth Management first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • Benson Wealth Management's AstraZeneca position peaked at $1.58K in Q1 2026.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Benson Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.